Official: Iran to Achieve Self-Sufficiency in Insulin Production in 5 years
“In terms of production of the final form of insulin, we have a relatively favorable situation, and a significant volume of the final form of insulin (pen and vial) is produced domestically. Of course, the pen form accounts for 40% of domestic production, and 60% of insulin pens are imported in pre-filled form,” Qaneyee said.
“Based on our experts' assessments, if we look realistically and considering the special conditions that have arisen for the country in recent months, during this period, 70% of the country's needs will probably be met, and it will probably take 3 to 5 years to reach 90% percent supply and ultimately complete self-sufficiency,” he added.
In 2023, a pharmaceutical company in Alborz province in Iran started production of a new generation of insulin for diabetic patients.
A ceremony was held at a pharmaceutical company in Alborz province attended by the head of Iran’s Food and Drug Administration (FDA), officials from the Ministry of Health and some other officials during which the production line of a new generation of insulin for diabetic patients was inaugurated.
After the ceremony, the production of new generation of insulin (combined immediate-acting and long-acting insulin) was started.
The FDA chairman, Heider Mohammadi said at the ceremony, "Every year, 30 million insulins are produced in the country.”
4155/v
